Concepedia
Statistics
Publications
17
Citations
962
H-Index
16
Active since
2009
Affiliations
University of Glasgow(Current)
University of Leicester
Monash University
Eli Lilly (United Kingdom)
Eli Lilly (United States)
Sophie J. Bradley is an author at University of Glasgow specializing in life sciences, muscarinic receptors, and pharmacology.
Publications per year
2009–2022
DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs<i>in Vitro</i>and<i>in Vivo</i>
Karen Thompson, Elham Khajehali, Sophie J. Bradley et al. · ACS Pharmacology & Translational Science · 2018 · 195 citations · Full text
Medicine, Neuroscience, Pharmacology +13
From structure to clinic: Design of a muscarinic M1 receptor agonist with the potential to treat Alzheimer’s disease
Alastair Brown, Sophie J. Bradley, Fiona H. Marshall et al. · Cell · 2021 · 97 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +14
M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss
Sophie J. Bradley, Julie-Myrtille Bourgognon, Helen Sanger et al. · Journal of Clinical Investigation · 2016 · 79 citations · Full text
Medicine, Neuroscience, Pharmacology +17
Chemogenetics defines receptor-mediated functions of short chain free fatty acids
Daniele Bolognini, Natasja Barki, Adrian J. Butcher et al. · Nature Chemical Biology · 2019 · 73 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +14
Clustered Coding Variants in the Glutamate Receptor Complexes of Individuals with Schizophrenia and Bipolar Disorder
René Frank, Allan F. McRae, Andrew Pocklington et al. · PLoS ONE · 2011 · 64 citations · Full text
Life Sciences, Genetics, Molecular Genetics +17
1–5 of 17